Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Cytokinetics (CYTK) Leases: 2020-2025

Historic Leases for Cytokinetics (CYTK) over the last 5 years, with Sep 2025 value amounting to $77.6 million.

  • Cytokinetics' Leases rose 1.62% to $77.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $77.6 million, marking a year-over-year increase of 1.62%. This contributed to the annual value of $75.2 million for FY2024, which is 4.85% down from last year.
  • Latest data reveals that Cytokinetics reported Leases of $77.6 million as of Q3 2025, which was up 1.92% from $76.1 million recorded in Q2 2025.
  • In the past 5 years, Cytokinetics' Leases ranged from a high of $83.0 million in Q2 2021 and a low of $72.2 million during Q2 2022.
  • In the last 3 years, Cytokinetics' Leases had a median value of $77.6 million in 2025 and averaged $78.1 million.
  • In the last 5 years, Cytokinetics' Leases spiked by 2,401.30% in 2021 and then fell by 13.07% in 2022.
  • Cytokinetics' Leases (Quarterly) stood at $73.1 million in 2021, then rose by 13.12% to $82.7 million in 2022, then decreased by 4.53% to $79.0 million in 2023, then fell by 4.85% to $75.2 million in 2024, then increased by 1.62% to $77.6 million in 2025.
  • Its last three reported values are $77.6 million in Q3 2025, $76.1 million for Q2 2025, and $77.4 million during Q1 2025.